Initial versus recent outcomes with a non-risk adapted surveillance policy in stage I non-seminomatous germ cell tumors (NSGCT)

被引：0
|
作者：
Duran, I. [1 ]
Sturgeon, J. F. [1 ]
Jewett, M. A. [1 ]
Anson-Cartwright, L. [1 ]
Berthold, D. R. [1 ]
Kakiashvili, D. [1 ]
Warde, P. R. [1 ]
Alison, R. E. [1 ]
Pond, G. R. [1 ]
Moore, M. J. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5021
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Non-risk adapted surveillance in stage I now seminomatous germ cell tumours (NSGCT): Improved recent outcomes
    Jewett, M.
    Moore, M.
    Warde, P.
    Anson-Cartwright, L.
    Kakiashvili, D.
    Berthold, D.
    Alison, R.
    Duran, I.
    Pond, G.
    Sturgeon, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 85 - 85
  • [2] Risk adapted surveillance for stage I non-seminomatous testicular tumors (NSGCT). Results of a prospective multicenter study.
    Maroto-Rey, P
    Del Muro, XG
    Paz-Ares, L
    Aparicio, J
    Sastre, J
    Dorca, J
    Terrassa, J
    Arranz, JA
    Barnadas, J
    Germa, JR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 387S - 387S
  • [3] Outcomes of surveillance protocol of clinical stage I non-seminomatous germ cell tumours; Is shift to risk-adapted policy justified?
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 97 - 97
  • [4] SURVEILLANCE ALONE IN CLINICAL STAGE-I NON-SEMINOMATOUS GERM-CELL TUMOR OF THE TESTIS (NSGCT)
    LO, RK
    JOHNSON, E
    VONESCHENBACH, C
    SWANSON, DA
    BRITISH JOURNAL OF UROLOGY, 1985, 57 (01): : 94 - 94
  • [5] Results of multimodality therapy in poor risk non-seminomatous germ cell tumors (NSGCT)
    Omuro, Y
    Sasaki, E
    Hayashi, C
    Okamoto, R
    Kobayashi, T
    Maeda, Y
    Sasaki, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 430 - 430
  • [6] Is a risk-adapted therapy possible in clinical stage I non-seminomatous testicular germ cell tumors?
    Heidenreich, A
    Neubauer, S
    Moul, JW
    AKTUELLE UROLOGIE, 1998, 29 (03) : 93 - 102
  • [7] Craniocaudal nodal length (CCNL) as a risk-factor for relapse in stage I non-seminomatous germ cell tumors (NSGCT).
    McHugh, Deaglan Joseph
    Fernandes, Maria Clara
    Funt, Samuel Aaron
    Bromberg, Maria
    Knezevic, Andrea
    Nikolovski, Ines
    Feldman, Darren R.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17011 - E17011
  • [8] Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours
    Maroto, P
    del Muro, XG
    Aparicio, J
    Paz-Ares, L
    Arranz, JA
    Guma, J
    Terrassa, J
    Barnadas, J
    Dorta, J
    Germà-Lluch, JR
    ANNALS OF ONCOLOGY, 2005, 16 (12) : 1915 - 1920
  • [9] TERATOMA WITH MALIGNANT TRANSFORMATION (TMT) IN NON-SEMINOMATOUS GERM CELL TUMORS (NSGCT)
    Shum, B.
    Tattersall, M.
    Grimison, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 69 - 69
  • [10] TRENDS IN STAGE I NON-SEMINOMATOUS GERM CELL TUMORS IN THE UNITED STATES
    Punjani, Nahid
    Seisen, Thomas
    Beard, Claire
    Sweeney, Christoper
    Quoc-Dien Trinh
    Rider, Jennifer
    Preston, Mark
    JOURNAL OF UROLOGY, 2017, 197 (04): : E930 - E930
12345